FDA Inspection 1198529 — OneBlood, Inc.

OneBlood, Inc. — FEI 1070194

The FDA completed an inspection of OneBlood, Inc. on Feb 3, 2023 in Bay Pines, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 3, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bay Pines, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.